Reach Us +443308085114
Editor - Bolin Geng | Merrimack Pharmaceuticals, Inc | 2070
ISSN: 1948-593X

Journal of Bioanalysis & Biomedicine
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Bolin Geng

Bolin Geng
Bolin Geng
Principal Scientist
Merrimack Pharmaceuticals, Inc.
Tel: 617- 441-1000


Bolin Geng is a Principal Scientist and Project Chemistry Leader of Liposome Therapeutics at Merrimack Pharmaceuticals in Cambridge, Mass. He received his PhD in organic chemistry from University of Montpellier, France in 1992, and has been working in pharmaceutical industry since 1995. He has over 50 publications, patents and patent applications and is the inventor or co-inventor of multiple clinical drug candidates.

Research Interest

Research Interests: Drug Discovery, Medicinal Chemistry, Anticancer and Antibacterial Agents, Novel Mode of Action, Enzyme Inhibition, Drug Resistance, Brand Drug Substances, Generic Drug Substances, Novel Drug Delivery, Liposome, Drug Physical Properties and Outsourcing Management.